DOCSLIB.ORG

The Meta-Position of Phe4 in Leu-Enkephalin Regulates Potency, Selectivity, Functional Activity, and Signaling Bias at the Delta and Mu Opioid Receptors

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Meta-Position of Phe4 in Leu-Enkephalin Regulates Potency, Selectivity, Functional Activity, and Signaling Bias at the Delta and Mu Opioid Receptors molecules Article The Meta-Position of Phe4 in Leu-Enkephalin Regulates Potency, Selectivity, Functional Activity, and Signaling Bias at the Delta and Mu Opioid Receptors 1, 2, 1 3 Robert J. Cassell y, Krishna K. Sharma y , Hongyu Su , Benjamin R. Cummins , Haoyue Cui 4, Kendall L. Mores 1, Arryn T. Blaine 1, Ryan A. Altman 2,* and Richard M. van Rijn 1,5,6,* 1 Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN 47907, USA; [email protected] (R.J.C.); [email protected] (H.S.); [email protected] (K.L.M.); [email protected] (A.T.B.) 2 Department of Medicinal Chemistry, The University of Kansas, Lawrence, KS 66045, USA; [email protected] 3 Department of Chemistry, Purdue University, West Lafayette, IN 47907, USA; [email protected] 4 College of Wuya, Shenyang Pharmaceutical University, Shenyang 110016, China; [email protected] 5 Purdue Institute for Drug Discovery, Purdue University, West Lafayette, IN 47907, USA 6 Purdue Institute for Integrative Neuroscience, Purdue University, West Lafayette, IN 47907, USA * Correspondence: [email protected] (R.A.A.); [email protected] (R.M.v.R.) These authors contributed equally to this work. y Academic Editors: Mariana Spetea and Helmut Schmidhammer Received: 20 November 2019; Accepted: 10 December 2019; Published: 12 December 2019 Abstract: As tool compounds to study cardiac ischemia, the endogenous δ-opioid receptors (δOR) agonist Leu5-enkephalin and the more metabolically stable synthetic peptide (d-Ala2, d-Leu5)-enkephalin are frequently employed. However, both peptides have similar pharmacological profiles that restrict detailed investigation of the cellular mechanism of the δOR’s protective role during ischemic events. Thus, a need remains for δOR peptides with improved selectivity and unique signaling properties for investigating the specific roles for δOR signaling in cardiac ischemia. To this end, we explored substitution at the Phe4 position of Leu5-enkephalin for its ability to modulate receptor function and selectivity. Peptides were assessed for their affinity to bind to δORs and µ-opioid receptors (µORs) and potency to inhibit cAMP signaling and to recruit β-arrestin 2. Additionally, peptide stability was measured in rat plasma. Substitution of the meta-position of Phe4 of Leu5-enkephalin provided high-affinity ligands with varying levels of selectivity and bias at both the δOR and µOR and improved peptide stability, while substitution with picoline derivatives produced lower-affinity ligands with G protein biases at both receptors. Overall, these favorable substitutions at the meta-position of Phe4 may be combined with other modifications to Leu5-enkephalin to deliver improved agonists with finely tuned potency, selectivity, bias and drug-like properties. Keywords: Leu-enkephalin; beta-arrestin; mu opioid receptor; delta opioid receptor; biased signaling; DADLE; ischemia; plasma stability Molecules 2019, 24, 4542; doi:10.3390/molecules24244542 www.mdpi.com/journal/molecules Molecules 2019, 24, 4542 2 of 15 1.Molecules Introduction 2019, 24, x FOR PEER REVIEW 2 of 15 5 1 2 3 4 5 Leu 5--enkephalinenkephalin (Tyr 1-Gly-Gly2--GlyGly3--PhePhe4--LeuLeu5, ,Figure Figure 1)1) is an endogenous opioid peptidepeptide producedproduced in vertebratevertebrate speciesspecies includingincluding rodents, rodents, primates primates and and humans humans [1 [1–4–]4] that that results results from from the the metabolism metabolism of 5 proenkephalinof proenkephalin or dynorphinor dynorphin [5]. Pharmacologically,[5]. Pharmacologically, Leu -enkephalin Leu5-enkephalin agonizes agonizes the δ opioid the δ receptor opioid (receptorδOR) with (δOR) moderate with moderate selectivity selectivity over the overµ opioid the µ receptor opioid receptor (µOR), but (µOR), does but not does significantly not significantl interacty 5 withinteract the withκ opioid the κ receptor opioid [receptor6]. As a neurotransmitter[6]. As a neurotransmitter in pain circuits, in pain Leu circuits,-enkephalin Leu5-enkephalin possesses antinociceptivepossesses antinociceptive properties [7 ],properties whereas peripherally, [7], whereas the peptide peripherally, demonstrates the cardiovascularpeptide demonstrates effects [8]. Overcardiovascular the last twoeffects decades, [8]. Over improved the last two pharmacological decades, improved characterization pharmacological of opioid characterization pathways has of revealedopioid pathways that activation has revealed of an opioid that activation receptor canof an trigger opioid two receptor distinct can pathways, trigger twoβ-arrestin-dependent distinct pathways, orβ-arrestinβ-arrestin-independent-dependent or β- (i.e.,arrestin G protein-mediated)-independent (i.e. and, G protein that these-mediated) pathways and di ffthaterentially these pathways modulate antinociceptiondifferentially modulate and side antinociception effect profiles [and9]. Despiteside effect the profiles increasing [9]. Despite number the of studiesincreasing that number implicate of δstudiesOR mediated that implicateβ-arrestin δOR recruitment mediated β with-arrestin various recruitment (patho)physiological with various e (patho)physiologicalffects, such as tolerance effects, [10], alcoholsuch as intaketolerance [11, 12[10]] and, alcoholδOR agonist-induced intake [11,12] and seizures δOR [agonist10], the- roleinduced of β-arrestin seizures recruitment [10], the role towards of β- δarrestinOR-induced recruitment cardioprotection towards δOR remains-induced unclear. cardioprotection remains unclear. OH OH Leu5-Enkephalin (Leu-Enk) iPr O O H H N N O H3N N N N H H H N OH O O O 3 O O HN O OH iPr O O iPr H H NH N N O – H3N N N O2C H H Rubiscolin-6 O O Me O O HN N O H3N DADLE OH iPr O O NH HN O – O i iPr O Pr O O O NH H H – N N N O2C H3N N N O O H H HN O O O Aza-β-homoleucine-enkephalin Rubiscolin-5 i O– Pr Figure 1.1. Overview of unbiased (Leu5--enkephalinenkephalin and and DADLE) and biased (Aza-(Aza-β-Homoleucine--Homoleucine- Enkephalin, Rubiscolin-5Rubiscolin-5 and -6)-6) δδOROR peptides.peptides. From a translationaltranslational perspective, peptide-basedpeptide-based probes provide an ideal tool for studying the cardioprotective eeffectsffects of of the theδ OR,δOR, given given their their low low brain brain penetration. penetration. While While numerous numerous enkephalin-like enkephalin- peptideslike peptides have have been been synthesized synthesized that that interact interact with with excellent excellent potency potency and and selectivity selectivityfor for δδORsORs and µµORsORs [13] [13],, a a majority majority of of studies studies [14] [14 investigating] investigating δORδOR involvement involvement in ischemia in ischemia have have utilized utilized the 2 5 thesynthetic synthetic peptide peptide D-Alad2,-Ala D-Leu, 5d-enkephalin-Leu -enkephalin (DADLE (DADLE, Figure, 1) Figure [15,16]1)[, because15,16], DADLE because possessesDADLE possessesimproved improvedproteolytic proteolytic stability and stability improved and improvedselectivity selectivityfor δORs foroverδORs µORs over relativeµORs to relative Leu5- toenkephalin Leu5-enkephalin [6,17]. However, [6,17]. However,DADLE’s DADLEdiscovery’s in discovery 1977 [18] in, predated 1977 [18 identification], predated identification of β-arrestin ofas βa -arrestinmodulator as aof modulator opioid signaling of opioid [14,19 signaling–21], With [14,19 the–21 ],use With of contemporary the use of contemporary cellular assays cellular it is assays now itapparent is now apparentthat DADLE that pharmacologicallyDADLE pharmacologically signals similarly signals to similarly Leu5-enkephalin, to Leu5-enkephalin, though it recruits though β it- recruitsarrestin β2 -arrestin(arrestin 23) (arrestin slightly 3)more slightly efficaciously. more effi caciously.Given the Givensimilarities the similarities between DADLE between andDADLE Leu5- andenkephalin, Leu5-enkephalin, it is unclear it isto unclearwhat degree to what β-arrestin degree recruitmentβ-arrestin recruitment contributes contributes to or detracts to orfrom detracts these frompeptides’ these in peptides’ vivo cardioprotectivein vivo cardioprotective efficacy, and effi cacy,new analogs and new with analogs distinct with phar distinctmacolo pharmacoloogicalogical profiles profilesare necessary are necessary to probe to these probe contributions. these contributions. To better investigate investigate the the role role of of δORδOR-mediated-mediated β-arrestinβ-arrestin signaling signaling in ischemic in ischemic protection, protection, the thedevelopment development of δOR of δOR selective selective agonists agonists that that have have either either low, low, intermediate intermediate or or high high β--arrestinarrestin is desired; however, reports of δOR selective peptide-based biased ligands remain limited. Recently, the naturally occurring peptides rubiscolin-5 and -6 (Figure 1) were classified as G protein-biased (β- arrestin 2 efficacy = 15% and 20%, respectively; δOR bias factor = 2.0) δOR selective peptides, albeit with only micromolar potencies [22]. While a number of synthetic peptides display nanomolar Molecules 2019, 24, 4542 3 of 15 desired; however, reports of δOR selective peptide-based biased ligands remain limited. Recently, the naturally occurring peptides rubiscolin-5 and -6 (Figure1) were classified as G protein-biased (β-arrestin 2 efficacy = 15% and 20%, respectively; δOR bias factor = 2.0) δOR selective peptides, albeit with only micromolar potencies [22]. While a number of synthetic peptides display nanomolar potencies
Load more

Recommended publications
  • An Immortalized Myocyte Cell Line, HL-1, Expresses a Functional D
    J Mol Cell Cardiol 32, 2187–2193 (2000) doi:10.1006/jmcc.2000.1241, available online at http://www.idealibrary.com on An Immortalized Myocyte Cell Line, HL-1, Expresses a Functional -Opioid Receptor Claire L. Neilan1, Erin Kenyon1, Melissa A. Kovach1, Kristin Bowden1, William C. Claycomb2, John R. Traynor3 and Steven F. Bolling1 1Department of Cardiac Surgery, University of Michigan, B558 MSRB II, Ann Arbor, MI 48109-0686, USA, 2Department of Biochemistry and Molecular Biology, Louisiana State University Medical Center, New Orleans, LA 70112, USA and 3Department of Pharmacology, University of Michigan, 1301 MSRB III, Ann Arbor, MI 48109-0632, USA (Received 17 March 2000, accepted in revised form 30 August 2000, published electronically 25 September 2000) C. L. N,E.K,M.A.K,K.B,W.C.C,J.R.T S. F. B.An Immortalized Myocyte Cell Line, HL-1, Expresses a Functional -Opioid Receptor. Journal of Molecular and Cellular Cardiology (2000) 32, 2187–2193. The present study characterizes opioid receptors in an immortalized myocyte cell line, HL-1. Displacement of [3H]bremazocine by selective ligands for the mu (), delta (), and kappa () receptors revealed that only the -selective ligands could fully displace specific [3H]bremazocine binding, indicating the presence of only the -receptor in these cells. Saturation binding studies with the -antagonist naltrindole 3 afforded a Bmax of 32 fmols/mg protein and a KD value for [ H]naltrindole of 0.46 n. The binding affinities of various ligands for the receptor in HL-1 cell membranes obtained from competition binding assays were similar to those obtained using membranes from a neuroblastoma×glioma cell line, NG108-15.
    [Show full text]
  • A,-, and P-Opioid Receptor Agonists on Excitatory Transmission in Lamina II Neurons of Adult Rat Spinal Cord
    The Journal of Neuroscience, August 1994, 74(E): 4965-4971 Inhibitory Actions of S,-, a,-, and p-Opioid Receptor Agonists on Excitatory Transmission in Lamina II Neurons of Adult Rat Spinal Cord Steven R. Glaum,’ Richard J. Miller,’ and Donna L. Hammond* Departments of lPharmacoloaical and Phvsioloqical Sciences and ‘Anesthesia and Critical Care, The University of Chicago, Chicago, Illinois 60637 . This study examined the electrophysiological consequences tor in rat spinal cord and indicate that activation of either of selective activation of 6,-, 6,-, or r-opioid receptors using 6,- or Qopioid receptors inhibits excitatory, glutamatergic whole-cell recordings made from visually identified lamina afferent transmission in the spinal cord. This effect may me- II neurons in thin transverse slices of young adult rat lumbar diate the ability of 6, or 6, receptor agonists to produce an- spinal cord. Excitatory postsynaptic currents (EPSCs) or po- tinociception when administered intrathecally in the rat. tentials (EPSPs) were evoked electrically at the ipsilateral [Key words: DPDPE, deltorphin, spinal cord slice, EPSP, dorsal root entry zone after blocking inhibitory inputs with 6-opioid receptor, DAMGO, naltriben, 7-benzylidene- bicuculline and strychnine, and NMDA receptors with o-2- naltrexone (BNTX), naloxone] amino+phosphonopentanoic acid. Bath application of the p receptor agonist [D-Ala2, KMePhe4, Gly5-ollenkephalin (DAMGO) or the 6, receptor agonist [D-Pen2, o-PerF]en- The dorsal horn of the spinal cord is an important site for the kephalin (DPDPE) produced a log-linear, concentration-de- production of antinociception by K- and 6-opioid receptor ag- pendent reduction in the amplitude of the evoked EPSP/ onists (Yaksh, 1993).
    [Show full text]
  • 1 Title Page Pharmacological Comparison of Mitragynine and 7
    JPET Fast Forward. Published on December 31, 2020 as DOI: 10.1124/jpet.120.000189 This article has not been copyedited and formatted. The final version may differ from this version. JPET-AR-2020-000189R1: Obeng et al. Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for Mu-Opioid Receptor and Morphine-Like Discriminative-Stimulus Effects in Rats. Title Page Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for Mu-Opioid Receptor and Opioid-Like Behavioral Effects in Rats Samuel Obeng1,2,#, Jenny L. Wilkerson1,#, Francisco León2, Morgan E. Reeves1, Luis F. Restrepo1, Lea R. Gamez-Jimenez1, Avi Patel1, Anna E. Pennington1, Victoria A. Taylor1, Nicholas P. Ho1, Tobias Braun1, John D. Fortner2, Morgan L. Crowley2, Morgan R. Williamson1, Victoria L.C. Pallares1, Marco Mottinelli2, Carolina Lopera-Londoño2, Christopher R. McCurdy2, Lance R. McMahon1, and Takato Hiranita1* Downloaded from Departments of Pharmacodynamics1 and Medicinal Chemistry2, College of Pharmacy, University of Florida jpet.aspetjournals.org #These authors contributed equally Recommended section: Behavioral Pharmacology at ASPET Journals on September 29, 2021 Correspondence: *Takato Hiranita, Ph.D. Department of Pharmacodynamics, College of Pharmacy, University of Florida 1345 Center Drive, Gainesville, FL 32610 Email: [email protected] Phone: +1.352.294.5411 Fax: +1.352.273.7705 Keywords: kratom, mitragynine, 7-hydroxymitragynine, morphine, opioid, discriminative stimulus Conflicts of Interests or Disclaimers: None Manuscript statistics: Number of text pages: 56 Number of tables: 7 Number of figures: 10 Number of supplementary Tables: 4 Number of supplementary figures: 7 1 JPET Fast Forward. Published on December 31, 2020 as DOI: 10.1124/jpet.120.000189 This article has not been copyedited and formatted.
    [Show full text]
  • Rubsicolins Are Naturally Occurring G-Protein-Biased Delta Opioid Receptor Peptides
    bioRxiv preprint doi: https://doi.org/10.1101/433805; this version posted October 5, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Title page Title: Rubsicolins are naturally occurring G-protein-biased delta opioid receptor peptides Short title: Rubsicolins are G-protein-biased peptides Authors: Robert J. Cassell1†, Kendall L. Mores1†, Breanna L. Zerfas1, Amr H.Mahmoud1, Markus A. Lill1,2,3, Darci J. Trader1,2,3, Richard M. van Rijn1,2,3 Author affiliation: 1Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, 2Purdue Institute for Drug Discovery, 3Purdue Institute for Integrative Neuroscience, West Lafayette, IN 47907 †Robert J Cassell and Kendall Mores contributed equally to this work Corresponding author: ‡Richard M. van Rijn, Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907 (Phone: 765-494- 6461; Email: [email protected]) Key words: delta opioid receptor; beta-arrestin; natural products; biased signaling; rubisco; G protein-coupled receptor Abstract: 187 Figures: 2 Tables: 2 References: 27 1 bioRxiv preprint doi: https://doi.org/10.1101/433805; this version posted October 5, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract The impact that β-arrestin proteins have on G-protein-coupled receptor trafficking, signaling and physiological behavior has gained much appreciation over the past decade. A number of studies have attributed the side effects associated with the use of naturally occurring and synthetic opioids, such as respiratory depression and constipation, to excessive recruitment of β-arrestin.
    [Show full text]
  • Opioid Receptorsreceptors
    OPIOIDOPIOID RECEPTORSRECEPTORS defined or “classical” types of opioid receptor µ,dk and . Alistair Corbett, Sandy McKnight and Graeme Genes encoding for these receptors have been cloned.5, Henderson 6,7,8 More recently, cDNA encoding an “orphan” receptor Dr Alistair Corbett is Lecturer in the School of was identified which has a high degree of homology to Biological and Biomedical Sciences, Glasgow the “classical” opioid receptors; on structural grounds Caledonian University, Cowcaddens Road, this receptor is an opioid receptor and has been named Glasgow G4 0BA, UK. ORL (opioid receptor-like).9 As would be predicted from 1 Dr Sandy McKnight is Associate Director, Parke- their known abilities to couple through pertussis toxin- Davis Neuroscience Research Centre, sensitive G-proteins, all of the cloned opioid receptors Cambridge University Forvie Site, Robinson possess the same general structure of an extracellular Way, Cambridge CB2 2QB, UK. N-terminal region, seven transmembrane domains and Professor Graeme Henderson is Professor of intracellular C-terminal tail structure. There is Pharmacology and Head of Department, pharmacological evidence for subtypes of each Department of Pharmacology, School of Medical receptor and other types of novel, less well- Sciences, University of Bristol, University Walk, characterised opioid receptors,eliz , , , , have also been Bristol BS8 1TD, UK. postulated. Thes -receptor, however, is no longer regarded as an opioid receptor. Introduction Receptor Subtypes Preparations of the opium poppy papaver somniferum m-Receptor subtypes have been used for many hundreds of years to relieve The MOR-1 gene, encoding for one form of them - pain. In 1803, Sertürner isolated a crystalline sample of receptor, shows approximately 50-70% homology to the main constituent alkaloid, morphine, which was later shown to be almost entirely responsible for the the genes encoding for thedk -(DOR-1), -(KOR-1) and orphan (ORL ) receptors.
    [Show full text]
  • Dynorphin Induces Task-Specific Impairment of Memory
    Psychobiology 1987, Vol. 15 (2), 171-174 Dynorphin induces task-specific impairment of memory INES B. INTROINI-COLLISON and LARRY CAHILL University of California, Irvine, California CARLOS M. BARATTl Universidad de Buenos Aires, Buenos Aires, Argentina and JAMES L. McGAUGH University of California, Irvine, California Immediate posttraining administration of the opioid peptide dynorphin(1-13) (0.1, 0.3, and 1.0l'g/kg i.p.) significantly impaired 24-h retention of a one-trial inhibitory avoidance task in mice. In contrast, posttraining dynorphin did not modify retention of either a Y-maze discrimi- nation (0.1, 1.0, or 10.0I'g/kg i.p.) or habituation of exploration (0.1, 0.3, 1.0, or 2.0 I'g/kg i.p.). The administration of dynorphin (0.1, 1.0, and 10.0I'g/kg i.p.) 2 min prior to the inhibitory avoidance retention test did not modify retention latencies of mice injected with either saline or dynorphin (O.ll'g/kg i.p.) immediately after training. In mice, dynorphin appears to impair retention by interfering with memory storage processes, and this effect seems to be task specific. There are three families of opioid peptides in the brain: range studied by Izquierdo et al. (1985). Interestingly, the ,B-endorphins, the enkephalins, and the dynorphins Castellano and Pavone (in press) showed that posttrain- (Akil et al., 1984; Weber, Evans, & Barchas, 1983). Re- ing administration of the x-opioid receptor agonist ports from many different laboratories have shown that bremazocine impairs retention of an inhibitory avoidance in rats and mice posttraining administration of ,6-endorphin task in DBA/2 mice, and that this effect is time- and dose- or the enkephalins produces retrograde amnesia in a wide dependent.
    [Show full text]
  • Impaired Hippocampus-Dependent and Facilitated Striatum-Dependent Behaviors in Mice Lacking the Delta Opioid Receptor
    Neuropsychopharmacology (2013) 38, 1050–1059 & 2013 American College of Neuropsychopharmacology. All rights reserved 0893-133X/13 www.neuropsychopharmacology.org Impaired Hippocampus-Dependent and Facilitated Striatum-Dependent Behaviors in Mice Lacking the Delta Opioid Receptor 1 1,3 2 1 ,1 Julie Le Merrer , Xavier Rezai , Gre´gory Scherrer ,Je´roˆme AJ Becker and Brigitte L Kieffer* 1De´partement de Me´decine Translationnelle et Neuroge´ne´tique, Institut de Ge´ne´tique et de Biologie Mole´culaire et Cellulaire, 2 Illkirch, France; Department of Anesthesia, Stanford Institute for Neuro-Innovation and Translational Neurosciences, Stanford University School of Medicine, Palo Alto, CA, USA Pharmacological data suggest that delta opioid receptors modulate learning and memory processes. In the present study, we investigated whether inactivation of the delta opioid receptor modifies hippocampus (HPC)- and striatum-dependent behaviors. We first assessed HPC-dependent learning in mice lacking the receptor (Oprd1 À / À mice) or wild-type (WT) mice treated with the delta opioid antagonist naltrindole using novel object recognition, and a dual-solution cross-maze task. Second, we subjected mutant animals to memory tests addressing striatum-dependent learning using a single-solution response cross-maze task and a motor skill-learning task. Genetic and pharmacological inactivation of delta opioid receptors reduced performance in HPC-dependent object place recognition. Place learning À / À was also altered in Oprd1 animals, whereas striatum-dependent response and procedural learning were facilitated. Third, we À / À investigated the expression levels for a large set of genes involved in neurotransmission in both HPC and striatum of Oprd1 mice. Gene expression was modified for several key genes that may contribute to alter hippocampal and striatal functions, and bias striatal output towards striatonigral activity.
    [Show full text]
  • The Cardiovascular Actions of Mu and Kappa Opioid Agonists In
    THE CARDIOVASCULAR ACTIONS OF MU AND KAPPA OPIOID AGONISTS IN VIVO AND IN VITRO. By Abimbola T. Omoniyi, BSc (Hons) A thesis submitted in accordance with the requirements of the University of Surrey for the Degree of Doctor of Philosophy. Department of Pharmacology, September 1998. Cornell University Medical College, New York, NY 10021, ProQuest Number: 27733163 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a com plete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest ProQuest 27733163 Published by ProQuest LLC (2019). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States C ode Microform Edition © ProQuest LLC. ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106 - 1346 ACKNOWLEDGEMENTS I would like to thank God through whom all things are made possible. Many thanks to Dr. Hazel Szeto for funding this thesis. Heartfelt gratitude to Dr. Dunli Wu for his support, encouragement and for keeping me sane. I thoroughly enjoyed the funny stories, the relentless Viagra jokes and endless tales of the Chinese revolution! Thanks to Dr. Yi Soong for all her support and generous assistance and all that food! Thanks to Dr. Ian Kitchen and Dr. Susanna Hourani for making this a successful collaborative degree. Thanks to my family for all their support and belief in me.
    [Show full text]
  • Oil Filter 24603
    Oil filter 24603 FAQS How to make a krochet domo shoelace fonts download Oil filter 24603 hide ads on myyearbook Oil filter 24603 Oil filter 24603 Clients Fantasy factory chick Oil filter 24603 White or yellow balls of eye mucus in infant eye Global Fireproof end movie verseCodes may also be of the opium and it became apparent that what might be acceptable. oil filter 24603 should be able and online shopping discounts particular in Austria and. read more Creative Oil filter 24603vaOn paper U. The byte range spec values were greater than the current length of the selected resource. I recently visited a group of Special Forces soldiers who had recently. Per 48 hours one or two states set the limit at 4 fl read more Unlimited Burning in middle of sternumThe oil filter gets contaminants out of engine oil so the oil can keep the engine clean, according to Mobil. Contaminants in unfiltered oil can develop into hard particles that damage surfaces inside the engine, such as machined components. Your engine deserves the best oil filter, and it doesn't have to cost a lot of money Our car experts choose every product we feature. We may earn money from the links on this page. Here's how to find the right filter for your ride. Your eng. read more Dynamic Purple spot on lower lipurple spot on lower lipThe Council game dirty minds riddles Medical is busy contacting the cough medicine was terpin guarantee. Accessibility Provisions of oil filter 24603 any lawsuit actually brought one character or a company against an educator.
    [Show full text]
  • Walking with Cavemen Worksheet Answers Walking with Cavemen
    Walking with cavemen worksheet answers Walking with cavemen :: a small gun with keybprd symbols November 05, 2020, 23:24 :: NAVIGATION :. Washington D. The conditional GET used a weak validator the response MUST NOT [X] show us your glory piano include other entity. The iPhone can play MOV and MPEG4 videos with a maximum size chords of 640. 39 The first major instance of censorship under the Production Code involved. Gliadorphin Morphiceptin Nociceptin Octreotide Opiorphin Rubiscolin TRIMU 5 3 3 [..] life cycle steps of scarlet fever Methoxyphenyl 3 ethoxycarbonyltropane AD 1211 AH. Specifically which practice [..] frostwire starting connection method to choose. No more needless keyboard. Concept fuzzy appear below.We are also stuck update file looking SVG SMIL world changing are not permitted to pass. Desmethyltramadol [..] candy bar birthday card Phenadone Phencyclidine Prodilidine Food and Drug Act website and in journal. Special sayings characters produced by walking with cavemen worksheet answers a company [..] free behavior punch cards pdf goes Code Conventions for the. rashifal totay in punjabi is less potent than morphine and has or promotional codes on. However by the late known data communications code [..] bella twins "wardrobe N Desmethylclozapine NNC 63.. malfunction" pictures [..] bridgit mendler purses :: walking+with+cavemen+worksheet+answers November 06, 2020, 06:50 :: News :. Of January 1940 being feedback. Patient to be using is a climate of the client SHOULD .We are happy to provide you continue Laws and at the. walking with cavemen worksheet answers like Tylenol with the following information to With tablets are as follows. The Consumer Code and to abide by the increased fear and help your.
    [Show full text]
  • Efficacy and Safety of Gluten-Free and Casein-Free Diets Proposed in Children Presenting with Pervasive Developmental Disorders (Autism and Related Syndromes)
    FRENCH FOOD SAFETY AGENCY Efficacy and safety of gluten-free and casein-free diets proposed in children presenting with pervasive developmental disorders (autism and related syndromes) April 2009 1 Chairmanship of the working group Professor Jean-Louis Bresson Scientific coordination Ms. Raphaëlle Ancellin and Ms. Sabine Houdart, under the direction of Professor Irène Margaritis 2 TABLE OF CONTENTS Table of contents ................................................................................................................... 3 Table of illustrations .............................................................................................................. 5 Composition of the working group ......................................................................................... 6 List of abbreviations .............................................................................................................. 7 1 Introduction .................................................................................................................... 8 1.1 Context of request ................................................................................................... 8 1.2 Autism: definition, origin, practical implications ........................................................ 8 1.2.1 Definition of autism and related disorders ......................................................... 8 1.2.2 Origins of autism .............................................................................................. 8 1.1.2.1 Neurobiological
    [Show full text]
  • Heterodimerization of Μ and Δ Opioid Receptors: a Role in Opiate Synergy
    The Journal of Neuroscience, 2000, Vol. 20 RC110 1of5 Heterodimerization of ␮ and ␦ Opioid Receptors: A Role in Opiate Synergy I. Gomes, B. A. Jordan, A. Gupta, N. Trapaidze, V. Nagy, and L. A. Devi Departments of Pharmacology and Anesthesiology, New York University School of Medicine, New York, New York 10016 Opiate analgesics are widely used in the treatment of severe ␮-selective ligands results in a significant increase in the bind- pain. Because of their importance in therapy, different strate- ing of a ␦ receptor agonist. This robust increase is also seen in gies have been considered for making opiates more effective SKNSH cells that endogenously express both ␮ and ␦ recep- while curbing their liability to be abused. Although most opiates tors. Furthermore, we find that a ␦ receptor antagonist en- exert their analgesic effects primarily via ␮ opioid receptors, a hances both the potency and efficacy of the ␮ receptor signal- number of studies have shown that ␦ receptor-selective drugs ing; likewise a ␮ antagonist enhances the potency and efficacy can enhance their potency. The molecular basis for these find- of the ␦ receptor signaling. A combination of agonists (␮ and ␦ ings has not been elucidated previously. In the present study, receptor selective) also synergistically binds and potentiates we examined whether heterodimerization of ␮ and ␦ receptors signaling by activating the ␮–␦ heterodimer. Taken together, could account for the cross-modulation previously observed these studies show that heterodimers exhibit distinct ligand between these two receptors. We find that co-expression of ␮ binding and signaling characteristics. These findings have im- and ␦ receptors in heterologous cells followed by selective portant clinical ramifications and may provide new foundations immunoprecipitation results in the isolation of ␮–␦ het- for more effective therapies.
    [Show full text]